Heart healthy=prostate healthy： SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms

The Selenium and Vitamin E Cancer Prevention Trial （SELECT） randomized over 35 000 men into four groups： high-dose vitamin E （400 IU day-1）, high-dose selenium （200 mcg day-1）, combination of vitamin E and selenium, or placebo.

Saved in:
Bibliographic Details
Published inAsian journal of andrology Vol. 14; no. 2; pp. 243 - 244
Main Author Moyad, Mark A
Format Journal Article
LanguageEnglish
Published China Medknow Publications & Media Pvt. Ltd 01.03.2012
Nature Publishing Group
Subjects
Antioxidants - adverse effects
Antioxidants - physiology
Diabetes Mellitus, Type 2 - epidemiology
Dose-Response Relationship, Drug
Follow-Up Studies
Heart - physiology
Humans
Male
Prostate - physiology
Prostatic Neoplasms - epidemiology
Prostatic Neoplasms - prevention & control
Research Highlight
Risk Factors
SELECT
Selenium - adverse effects
Selenium - therapeutic use
Skin Neoplasms - epidemiology
Vitamin E - adverse effects
Vitamin E - therapeutic use
前列腺癌
心脏健康
抗氧化机制
维生素E
象征
预防试验
高剂量
Online AccessGet full text

Cover

More Information
Summary:The Selenium and Vitamin E Cancer Prevention Trial （SELECT） randomized over 35 000 men into four groups： high-dose vitamin E （400 IU day-1）, high-dose selenium （200 mcg day-1）, combination of vitamin E and selenium, or placebo.
Bibliography:The Selenium and Vitamin E Cancer Prevention Trial （SELECT） randomized over 35 000 men into four groups： high-dose vitamin E （400 IU day-1）, high-dose selenium （200 mcg day-1）, combination of vitamin E and selenium, or placebo.
31-1795/R
ISSN:1008-682X
1745-7262
DOI:10.1038/aja.2011.174